Zurueck zur Suche

Reporte zur Charge U019906

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 3 CA 2 NC 1 NY 1 AZ 1 MN 1 IN 1 NJ 1 CO 1 MI 1 AK 1

VAERS 1951260

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

schwer
Staat
NC
Alter
1,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
02.12.2021
Beginn
11.12.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Febrile convulsion

Symptomtext

Febrile seizure nine days after administration of vaccines, evaluated in ED, possible AOM at the time, started antibiotics. Fever did not return and was 102 the day of the ED visit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Eggs, nickel, benzyl alcohol, benzoate 4, peanuts, sesquiterpene lactones.
Vorherige Impfungen
-

VAERS 2088904

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

mild
Staat
CA
Alter
6,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Rash

Symptomtext

Mom states the patient developed a rash all over his body, a high fever controlled by Tylenol.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergic Rhinitis
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1958498

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

mild
Staat
NY
Alter
4,0
Geschlecht
M
Eingang
07.12.2021
Impfdatum
29.11.2021
Beginn
01.12.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site reaction

Symptomtext

Large local reaction 24-28hr after 4 year old immunizations on R arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2681332

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
AZ
Alter
48,0
Geschlecht
M
Eingang
12.09.2023
Impfdatum
12.09.2023
Beginn
12.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

vaccine expired 6/24/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
we will be ordering a titer
Aktuelle Erkrankungen
Hyperlipidemia
Vorgeschichte
-
Andere Medikamente
-
Allergien
Penicillin's
Vorherige Impfungen
-

VAERS 2673052

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
MN
Alter
-
Geschlecht
U
Eingang
18.08.2023
Impfdatum
20.07.2023
Beginn
20.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

HCP reported administration of expired VARIVAX to a patient. No symptoms reported. VARIVAX previously experienced a TE (Case #02098347). New TE documented for escalation (Case #02432659). Obtained consent to contact HCP. No additional AE/PQC. After; Expired vaccine used; This spontaneous report was received from Pharmacist and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-JUL-2023, the patient was vaccinated with an expired varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5ml dose, lot #U019906, expiration date: 24-JUN-2023 (strength, route of administration, and indication were not provided) (Expired vaccine used). No symptoms reported. After the call, it was identified a miscommunication regarding information for expired administered products in which had a prior temperature excursion (Product storage error). Unsuccessful call-back attempt was made.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643505

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
IN
Alter
1,1
Geschlecht
F
Eingang
09.06.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

Patient is okay

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603597

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
NJ
Alter
17,0
Geschlecht
U
Eingang
24.03.2023
Impfdatum
08.03.2023
Beginn
08.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

HCP called to state that a patient was given a dose of VARIVAX with a temperature excursion that had a unsupported outcome.; This spontaneous report was received from a medical assistant and refers to a 17-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-MAR-2023, the patient was vaccinated with varicella virus vaccine live (OKA/MERCK) (VARIVAX) valid lot #U019906, expiration date: 24-JUN-2023, administered for prophylaxis (dose, frequency, anatomical location, strength, and route of administration were not provided). It was reported that the dose experienced a temperature excursion (Product storage error).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2446490

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
CA
Alter
1,1
Geschlecht
F
Eingang
15.09.2022
Impfdatum
09.09.2022
Beginn
09.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient received extra dose of Varicella vaccine accidently. Mother made aware through phone call by Provider and Nursing Director. Per mother child is stable, no changes, mother reports no symptoms at this time. Advised to give Tylenol PRN and monitor patient for any changes, if changes occur take child to Emergency room. RTC for Follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
Npne
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2428200

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
CO
Alter
25,0
Geschlecht
M
Eingang
02.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Electrocardiogram normal Hyperhidrosis Hypophagia Laboratory test Lethargy Pallor Pulse abnormal

Symptomtext

Patient was given Varivax subcutaneous in left arm tricep area, MMR II right arm tricep area, and Hepatitis B Hepislav-B IM in left deltoid around 11:45 AM in a clinic setting by me. After giving all vaccines patient became lethargic, diaphoretic, pallor, and had a thready pulse of 20-30s after 1 minute. Patient legs were elevated and patient was reclined on exam table. EMS was called and patient remained lethargic, pale, with pulse in 20-30s, with pulse oximeter of 85% on room air (we do not have oxygen in this clinic). Gave patient an ammonia inhalant and patient began to be more conversant after 5 minutes. Pulse now in 40-50s. Paramedics arrived after 5 minutes, patient now alert and oriented, EKG performed and patient was in sinus rhythm. Patient was taken to Hospital for further work up but was discharged around 2:00 PM. Patient came back by clinic to thank clinic staff. Patient did inform staff after the situation that he had not eaten, had worked out and taken pre-workout before vaccination appointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electrocardiogram normal
Hospital-Tage
-
Labordaten
9/2 EKG-sinus rhythm
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2334799

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
25.06.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs or PQC reported.; Caller reported VARIVAX administered after temperature excursion. No additional information provided. No additional AEs or PQC reported. ? Names of vaccines involved (including lot/exp) VARIVAX U019906 6/24/2023 ? Temperatur; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-APR-2022, the patient was vaccinated with improperly stored (varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter subcutaneously, lot #U019906, expiration date: 24-JUN-2023, administered for prophylaxis (strength, and site of administration were not provided) (product storage error temperature too high). The vaccine was stored in the temperature of 6.8 Fahrenheit degrees for 1 hour and 36 minutes. No previous temperature excursion reported. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2314127

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
MI
Alter
7,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
07.06.2022
Beginn
07.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

No health related issues. Varicella was given 14 days after MMR vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
No tests, no concerns
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
NA
Allergien
no allergies reported
Vorherige Impfungen
-

VAERS 2302894

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
31.05.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs or PQC reported.; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report was received from a physician referring to a patient of unknown age and gender. Information about patient's pertinent medical history, concomitant medications, concurrent conditions and drug reactions/ allergies was not provided. On 24-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), dose of 0.5 mL, administered subcutaneously, lot number: U019906, expiration date: 24-JUN-2023 (dose number was not provided) for prophylaxis (product storage error). No additional adverse events (AEs) or product quality complaint (PQC) was reported (no adverse event). The administered dose of the vaccine experienced temperature excursion of 6.8 degrees Fahrenheit (F) for 1 hour and 36 minutes and 6.0 F for 36 minutes. There were no previous reported temperature excursions. It was unknown if a digital data logger was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2302892

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
31.05.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AEs; VARIVAX administered after temperature excursion; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies were not reported. On 21-APR-2022, improperly stored, varicella virus vaccine live (oka/merck) (VARIVAX) 0,5 milliliter, lot #U019906, expiration date: 24-JUN-2023, subcutaneously was administered for prophylaxis. The vaccine experienced a temperature excursion of 6.8 degree Fahrenheit for 1 hour and 36 minutes (product storage error). There was no previous temperature excursion. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2140508

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U019906

gering
Staat
AK
Alter
34,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

Pt. presented to New Hire Orientation on 2/22/2022. She presented as a healthy individual and filled out a screening form for administration of vaccines. The CMA that was administering vaccines did not see screener and missed that pt. checked that she was pregnant. Pt. denied allergies or any other vaccines received in last 4 weeks on form. CMA administered both MMR and Varicella to pt. Pt. stated that she is 2 months pregnant (approximately 8 weeks) which would put her EDD at 10/5/2022. She was advised to contact her prenatal care provider for further follow up and guidance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-